Abstract
Only doubling or tripling α-synuclein expression significantly increases the risk of developing Parkinson's disease. In this issue of Neuron, Nemani et al. show that this modest overexpression of α-synuclein does not lead to obvious toxicity in the near term, but impairs glutamate and dopamine release, potentially leading to broad network dysfunction and eventual pathology.
Original language | English (US) |
---|---|
Pages (from-to) | 3-4 |
Number of pages | 2 |
Journal | Neuron |
Volume | 65 |
Issue number | 1 |
DOIs | |
State | Published - Jan 14 2010 |
ASJC Scopus subject areas
- General Neuroscience